BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Oliveira HC, Joffe LS, Simon KS, Castelli RF, Reis FCG, Bryan AM, Borges BS, Medeiros LCS, Bocca AL, Del Poeta M, Rodrigues ML. Fenbendazole Controls In Vitro Growth, Virulence Potential, and Animal Infection in the Cryptococcus Model. Antimicrob Agents Chemother 2020;64:e00286-20. [PMID: 32253211 DOI: 10.1128/AAC.00286-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Basha NJ. Therapeutic Efficacy of Benzimidazole and Its Analogs: An Update. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2118334] [Reference Citation Analysis]
2 Castelli RF, Pereira A, Honorato L, Valdez A, de Oliveira HC, Bazioli JM, Garcia AWA, Klimeck TDF, Reis FCG, Staats CC, Nimrichter L, Fill TP, Rodrigues ML, Bäumler AJ. Extracellular Vesicle Formation in Cryptococcus deuterogattii Impacts Fungal Virulence and Requires the NOP16 Gene. Infect Immun. [DOI: 10.1128/iai.00232-22] [Reference Citation Analysis]
3 Lim W, Verbon A, van de Sande W. Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach. Expert Opin Drug Discov 2022. [PMID: 35612364 DOI: 10.1080/17460441.2022.2080195] [Reference Citation Analysis]
4 Bezerra GSN, Colbert DM, O’donnell C, Cao Z, Geever J, Geever L. Compatibility Study Between Fenbendazole and Poly(Ethylene Oxide) with Application in Solid Dispersion Formulations Using Hot-Melt Extrusion. J Pharm Innov. [DOI: 10.1007/s12247-022-09644-y] [Reference Citation Analysis]
5 Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, Bonifaz A, Todd M, Perry B, Samby K, Burrows J, Verbon A, van de Sande W. Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma. PLoS Negl Trop Dis 2022;16:e0010159. [PMID: 35120131 DOI: 10.1371/journal.pntd.0010159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chan YS, Chong KP. Bioactive Compounds of Ganoderma boninense Inhibited Methicillin-Resistant Staphylococcus aureus Growth by Affecting Their Cell Membrane Permeability and Integrity. Molecules 2022;27:838. [PMID: 35164103 DOI: 10.3390/molecules27030838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Oliveira EAM, Ferreira GF, Lang KL. Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review. Med Chem Res 2022;31:26-39. [DOI: 10.1007/s00044-021-02824-4] [Reference Citation Analysis]
8 Marcos CM, de Oliveira HC, Assato PA, Castelli RF, Fusco-Almeida AM, Mendes-Giannini MJS. Drk1, a Dimorphism Histidine Kinase, Contributes to Morphology, Virulence, and Stress Adaptation in Paracoccidioides brasiliensis. J Fungi (Basel) 2021;7:852. [PMID: 34682273 DOI: 10.3390/jof7100852] [Reference Citation Analysis]
9 Sutar Y, Fulton SR, Paul S, Altamirano S, Mhatre S, Saeed H, Patel P, Mallick S, Bhat R, Patravale VB, Chauhan H, Nielsen K, Date AA. Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. ACS Infect Dis 2021;7:2637-49. [PMID: 34467755 DOI: 10.1021/acsinfecdis.1c00063] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 de Oliveira HC, Rodrigues ML. Repurposing benzimidazoles to fight Cryptococcus. Fungal Biology Reviews 2021;37:27-40. [DOI: 10.1016/j.fbr.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Podlipná R, Navrátilová M, Raisová Stuchlíková L, Moťková K, Langhansová L, Skálová L, Szotáková B. Soybean (Glycine max) Is Able to Absorb, Metabolize and Accumulate Fenbendazole in All Organs Including Beans. Int J Mol Sci 2021;22:6647. [PMID: 34206260 DOI: 10.3390/ijms22136647] [Reference Citation Analysis]
12 Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol 2021;19:454-66. [PMID: 33558691 DOI: 10.1038/s41579-021-00511-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]